lifestyle.travelshq.com

Author: CNS Pharmaceuticals, Inc.

CNS Pharmaceuticals Announces Oversubscribed $22.5 Million Private Placement Financing

May 4, 2026
CNS Pharmaceuticals Launches New Corporate Strategy Focused on Building a High-Value Neurology and Oncology Pipeline

March 11, 2026
CNS Pharmaceuticals Appoints Lynne Kelley, MD, FACS, as Chief Medical Officer, Completing Executive Leadership Team

March 2, 2026
CNS Pharmaceuticals Appoints Multiple Key Executives to Drive Company’s Recently Initiated Strategic Transformation

February 17, 2026
CNS Pharmaceuticals Issues Letter to Shareholders

January 29, 2026
CNS Pharmaceuticals Announces CEO Transition

December 19, 2025